| Primary information |
|---|
| ID | 12861 |
| Uniprot ID | P01282 |
| Description | VIP peptides [Cleaved into- Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the glucagon family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | VIP causes vasodilation; lowers arterial blood pressure; stimulates myocardial contractility; increases glycogenolysis and relaxes the smooth muscle of trachea; stomach and gall bladder. |
| Length | 170 |
| Molecular Weight | 19 |
| Name | VIP peptides |
| Sequence | HSDAVFTDNYTRLRKQMAVKKYLNSILN |
| Sequence map | 672 |
| PDB ID | 6571696; 3899557; 2995945; 3025882; 2839091; 14574404; 15489334; 3748844; 6139527; 2434617; |
| Drugpedia | 2RRH;2RRI; |
| Receptor | P30988; P32241; P41587 |
| Domain | NA |
| Pharmaceutical Use | NA
|